Primed Shines Animal Welfare Assurance was approved by NIH Office of Laboratory Animal Welfare (OLAW) in August, 2019 (Assurance Identification number F19-00450). Achieving OLAW certification, Primed Shines has been qualified to undertake various animal study projects funded by the National Institutes of Health (NIH).

Join us for the annual assembly—the BioJapan Parternering Event—between October 9th and 10th at Yokohama, Japan, in which the Primed Shines Team will be exhibiting their latest spontaneous and induced NHP models to both present and potential partners. The six-member team, including the CEO, as well as members from the Business Development and R&D department, will be at booth D-131.

Between 28thApril and 2ndMay, drop by our exhibition spot at the Association for Research in Vision & Ophthalmology Annual Meeting (ARVO) 2019. Learn more about the services that Primed offers in spontaneous NHP Ophthalmology disease models at booth #1441, which is located inside of Vancouver Convention Center.ARVO hosts the largest meeting of eye and vision researchers in the world. This year’s

This end of September, vision scientists and researchers from Harvard Medical School Harvard Ophthalmology /Mass. Eye and Ear (MEEI)came together to discuss the latest eye-research topics that ranges from novel biomarkers and vascular pathogenesis to inflammation. This workshop is to accelerate innovative eye research using NHP research and to eradicate blinding diseases. MEEI is a global center f

ARVO Annual Meeting is the world's largest academic conference for ophthalmology and visual research. It brings together the world's top ophthalmologists and international cutting-edge research results, with more than 11,000 basic and clinical researchers from 75 countries around the world participate in the conference, providing an international platform for the world's ophthalmology

April 18, 2018Primed Shines Co., Ltd, a leading science-driven, technologically advanced, high-quality preclinical research partner, will showcase their scientific expertise of ocular disease in nonhuman primates at this year’s meeting of...

“The history of cancer research has been a history of curing cancer in the mouse. We have cured mice of cancer for decades—and it simply didn’t work in humans.” This statement was made by Richard Klausner, M.D., former director of the...

In March 2018, Baowen Li joined Primed Team as the chief operation officer and vice president. Professor Li was the deputy director of Laboratory Animal Resource Institute, Safety Evaluation Center, and the director of Animal Management Department of National Institutes for Food and Drug Control. He currently serves as the GLP reviewer for Chinese Food and Drug Administration, committee expert of

The Association for the Assessment and Accreditation of Laboratory Animal (AAALAC) is an international recognized, non-profit organization that promote the humane treatment of laboratory animals in science through voluntary accreditation and assessment programs. On March 5th, 2018, Primed Bio-tech Group Co., Ltd, a leading science-driven, technologically advanced, high-quality preclinical research

In January, doctor Chen was appointed as our senior consultant in ophthalmic disease research. She is one of the associate scientists at Schepens Eye Research Institute and associate professor at Harvard Medical School. She has extensive experience and knowledge on eye research. Her professional and academic memberships include NIH Peer Review Committee, ARVO, APAO and Women’s Eye Health Organiza